Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence

Jennifer Wessel, Sarah M. McDonald, David A. Hinds, Renee P. Stokowski, Harold S. Javitz, Michael Kennemer, Ruth Krasnow, William Dirks, Jill Hardin, Steven J. Pitts, Martha Michel, Lisa Jack, Dennis G. Ballinger, Jennifer B. McClure, Gary E. Swan, Andrew W. Bergen

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Common single-nucleotide polymorphisms (SNPs) at nicotinic acetylcholine receptor (nAChR) subunit genes have previously been associated with measures of nicotine dependence. We investigated the contribution of common SNPs and rare single-nucleotide variants (SNVs) in nAChR genes to Fagerström test for nicotine dependence (FTND) scores in treatment-seeking smokers. Exons of 10 genes were resequenced with next-generation sequencing technology in 448 European-American participants of a smoking cessation trial, and CHRNB2 and CHRNA4 were resequenced by Sanger technology to improve sequence coverage. A total of 214 SNP/SNVs were identified, of which 19.2% were excluded from analyses because of reduced completion rate, 73.9% had minor allele frequencies 5%, and 48.1% were novel relative to dbSNP build 129. We tested associations of 173 SNP/SNVs with the FTND score using data obtained from 430 individuals (18 were excluded because of reduced completion rate) using linear regression for common, the cohort allelic sum test and the weighted sum statistic for rare, and the multivariate distance matrix regression method for both common and rare SNP/SNVs. Association testing with common SNPs with adjustment for correlated tests within each gene identified a significant association with two CHRNB2 SNPs, eg, the minor allele of rs2072660 increased the mean FTND score by 0.6 Units (P0.01). We observed a significant evidence for association with the FTND score of common and rare SNP/SNVs at CHRNA5 and CHRNB2, and of rare SNVs at CHRNA4. Both common and/or rare SNP/SNVs from multiple nAChR subunit genes are associated with the FTND score in this sample of treatment-seeking smokers.

Original languageEnglish
Pages (from-to)2392-2402
Number of pages11
JournalNeuropsychopharmacology
Volume35
Issue number12
DOIs
StatePublished - Nov 2010

Fingerprint

Tobacco Use Disorder
Nicotinic Receptors
Single Nucleotide Polymorphism
Nucleotides
Genes
Technology
Smoking Cessation
Gene Frequency
Exons
Linear Models
Alleles

Keywords

  • candidate gene association scan
  • Fagerström test for nicotine dependence
  • single-nucleotide polymorphism
  • treatmentseeking smokers

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health

Cite this

Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. / Wessel, Jennifer; McDonald, Sarah M.; Hinds, David A.; Stokowski, Renee P.; Javitz, Harold S.; Kennemer, Michael; Krasnow, Ruth; Dirks, William; Hardin, Jill; Pitts, Steven J.; Michel, Martha; Jack, Lisa; Ballinger, Dennis G.; McClure, Jennifer B.; Swan, Gary E.; Bergen, Andrew W.

In: Neuropsychopharmacology, Vol. 35, No. 12, 11.2010, p. 2392-2402.

Research output: Contribution to journalArticle

Wessel, J, McDonald, SM, Hinds, DA, Stokowski, RP, Javitz, HS, Kennemer, M, Krasnow, R, Dirks, W, Hardin, J, Pitts, SJ, Michel, M, Jack, L, Ballinger, DG, McClure, JB, Swan, GE & Bergen, AW 2010, 'Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence', Neuropsychopharmacology, vol. 35, no. 12, pp. 2392-2402. https://doi.org/10.1038/npp.2010.120
Wessel, Jennifer ; McDonald, Sarah M. ; Hinds, David A. ; Stokowski, Renee P. ; Javitz, Harold S. ; Kennemer, Michael ; Krasnow, Ruth ; Dirks, William ; Hardin, Jill ; Pitts, Steven J. ; Michel, Martha ; Jack, Lisa ; Ballinger, Dennis G. ; McClure, Jennifer B. ; Swan, Gary E. ; Bergen, Andrew W. / Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. In: Neuropsychopharmacology. 2010 ; Vol. 35, No. 12. pp. 2392-2402.
@article{82ecee21441a4af795be1435eb2a4111,
title = "Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerstr{\"o}m test for nicotine dependence",
abstract = "Common single-nucleotide polymorphisms (SNPs) at nicotinic acetylcholine receptor (nAChR) subunit genes have previously been associated with measures of nicotine dependence. We investigated the contribution of common SNPs and rare single-nucleotide variants (SNVs) in nAChR genes to Fagerstr{\"o}m test for nicotine dependence (FTND) scores in treatment-seeking smokers. Exons of 10 genes were resequenced with next-generation sequencing technology in 448 European-American participants of a smoking cessation trial, and CHRNB2 and CHRNA4 were resequenced by Sanger technology to improve sequence coverage. A total of 214 SNP/SNVs were identified, of which 19.2{\%} were excluded from analyses because of reduced completion rate, 73.9{\%} had minor allele frequencies 5{\%}, and 48.1{\%} were novel relative to dbSNP build 129. We tested associations of 173 SNP/SNVs with the FTND score using data obtained from 430 individuals (18 were excluded because of reduced completion rate) using linear regression for common, the cohort allelic sum test and the weighted sum statistic for rare, and the multivariate distance matrix regression method for both common and rare SNP/SNVs. Association testing with common SNPs with adjustment for correlated tests within each gene identified a significant association with two CHRNB2 SNPs, eg, the minor allele of rs2072660 increased the mean FTND score by 0.6 Units (P0.01). We observed a significant evidence for association with the FTND score of common and rare SNP/SNVs at CHRNA5 and CHRNB2, and of rare SNVs at CHRNA4. Both common and/or rare SNP/SNVs from multiple nAChR subunit genes are associated with the FTND score in this sample of treatment-seeking smokers.",
keywords = "candidate gene association scan, Fagerstr{\"o}m test for nicotine dependence, single-nucleotide polymorphism, treatmentseeking smokers",
author = "Jennifer Wessel and McDonald, {Sarah M.} and Hinds, {David A.} and Stokowski, {Renee P.} and Javitz, {Harold S.} and Michael Kennemer and Ruth Krasnow and William Dirks and Jill Hardin and Pitts, {Steven J.} and Martha Michel and Lisa Jack and Ballinger, {Dennis G.} and McClure, {Jennifer B.} and Swan, {Gary E.} and Bergen, {Andrew W.}",
year = "2010",
month = "11",
doi = "10.1038/npp.2010.120",
language = "English",
volume = "35",
pages = "2392--2402",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence

AU - Wessel, Jennifer

AU - McDonald, Sarah M.

AU - Hinds, David A.

AU - Stokowski, Renee P.

AU - Javitz, Harold S.

AU - Kennemer, Michael

AU - Krasnow, Ruth

AU - Dirks, William

AU - Hardin, Jill

AU - Pitts, Steven J.

AU - Michel, Martha

AU - Jack, Lisa

AU - Ballinger, Dennis G.

AU - McClure, Jennifer B.

AU - Swan, Gary E.

AU - Bergen, Andrew W.

PY - 2010/11

Y1 - 2010/11

N2 - Common single-nucleotide polymorphisms (SNPs) at nicotinic acetylcholine receptor (nAChR) subunit genes have previously been associated with measures of nicotine dependence. We investigated the contribution of common SNPs and rare single-nucleotide variants (SNVs) in nAChR genes to Fagerström test for nicotine dependence (FTND) scores in treatment-seeking smokers. Exons of 10 genes were resequenced with next-generation sequencing technology in 448 European-American participants of a smoking cessation trial, and CHRNB2 and CHRNA4 were resequenced by Sanger technology to improve sequence coverage. A total of 214 SNP/SNVs were identified, of which 19.2% were excluded from analyses because of reduced completion rate, 73.9% had minor allele frequencies 5%, and 48.1% were novel relative to dbSNP build 129. We tested associations of 173 SNP/SNVs with the FTND score using data obtained from 430 individuals (18 were excluded because of reduced completion rate) using linear regression for common, the cohort allelic sum test and the weighted sum statistic for rare, and the multivariate distance matrix regression method for both common and rare SNP/SNVs. Association testing with common SNPs with adjustment for correlated tests within each gene identified a significant association with two CHRNB2 SNPs, eg, the minor allele of rs2072660 increased the mean FTND score by 0.6 Units (P0.01). We observed a significant evidence for association with the FTND score of common and rare SNP/SNVs at CHRNA5 and CHRNB2, and of rare SNVs at CHRNA4. Both common and/or rare SNP/SNVs from multiple nAChR subunit genes are associated with the FTND score in this sample of treatment-seeking smokers.

AB - Common single-nucleotide polymorphisms (SNPs) at nicotinic acetylcholine receptor (nAChR) subunit genes have previously been associated with measures of nicotine dependence. We investigated the contribution of common SNPs and rare single-nucleotide variants (SNVs) in nAChR genes to Fagerström test for nicotine dependence (FTND) scores in treatment-seeking smokers. Exons of 10 genes were resequenced with next-generation sequencing technology in 448 European-American participants of a smoking cessation trial, and CHRNB2 and CHRNA4 were resequenced by Sanger technology to improve sequence coverage. A total of 214 SNP/SNVs were identified, of which 19.2% were excluded from analyses because of reduced completion rate, 73.9% had minor allele frequencies 5%, and 48.1% were novel relative to dbSNP build 129. We tested associations of 173 SNP/SNVs with the FTND score using data obtained from 430 individuals (18 were excluded because of reduced completion rate) using linear regression for common, the cohort allelic sum test and the weighted sum statistic for rare, and the multivariate distance matrix regression method for both common and rare SNP/SNVs. Association testing with common SNPs with adjustment for correlated tests within each gene identified a significant association with two CHRNB2 SNPs, eg, the minor allele of rs2072660 increased the mean FTND score by 0.6 Units (P0.01). We observed a significant evidence for association with the FTND score of common and rare SNP/SNVs at CHRNA5 and CHRNB2, and of rare SNVs at CHRNA4. Both common and/or rare SNP/SNVs from multiple nAChR subunit genes are associated with the FTND score in this sample of treatment-seeking smokers.

KW - candidate gene association scan

KW - Fagerström test for nicotine dependence

KW - single-nucleotide polymorphism

KW - treatmentseeking smokers

UR - http://www.scopus.com/inward/record.url?scp=77958012303&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77958012303&partnerID=8YFLogxK

U2 - 10.1038/npp.2010.120

DO - 10.1038/npp.2010.120

M3 - Article

C2 - 20736995

AN - SCOPUS:77958012303

VL - 35

SP - 2392

EP - 2402

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 12

ER -